Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 16,151–16,175 of 27,380 studies, newest first · page 647 of 1096.

April 2016 25

  1. 2016-04-11

    Initiating advance care planning on end-of-life issues in dementia: Ambiguity among UK and Dutch physicians

    ✓ Peer-reviewed End-of-life care Archives of gerontology and geriatrics

    Key finding: There is considerable ambiguity about initiating ACP in dementia at diagnosis among physicians practicing in two different European health care systems and caring for different patient populations. +1 more finding

  2. 2016-04-11

    Dementia in Down's syndrome

    ✓ Peer-reviewed Brain tissue and pathology The Lancet. Neurology

    Key finding: Genetic drivers result in a high frequency of Alzheimer's pathology in these individuals, evident from neuroimaging, biomarker, and neuropathological findings, and a high incidence of cognitive decline and dementia. +3 more findings

  3. 2016-04-09

    Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease

    ✓ Peer-reviewed Getting a diagnosis Acta neuropathologica

    Key finding: Recent observations suggest that there is a vascular basis for neuronal atrophy in both the temporal and frontal lobes in VaD that is entirely independent of any Alzheimer pathology. +1 more finding

  4. 2016-04-08

    The Effects of Cognitive Training for Elderly: Results from My Mind Project

    ✓ Peer-reviewed Prevention trials Rejuvenation research

    Key finding: In the three groups, immediately after the end of the intervention, we observed a significant effect on some cognitive and noncognitive outcomes in the EGs. +4 more findings

  5. 2016-04-08

    Green-Fluorescent Protein(+) Astrocytes Attach to Beta-Amyloid Plaques in an Alzheimer Mouse Model and Are Sensitive for Clasmatodendrosis

    ✓ Peer-reviewed Biomarkers Frontiers in aging neuroscience

    Key finding: Three-dimensional confocal microscopy revealed a tight association and intense sprouting of astrocytic finely branched processes towards Aβ plaques in 12 month old mice. +1 more finding

  6. 2016-04-08

    CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

    ✓ Peer-reviewed Biomarkers The Lancet. Neurology

    Key finding: The core biomarkers differentiated Alzheimer's disease from controls with good performance: CSF T-tau (average ratio 2·54, 95% CI 2·44-2·64, p<0·0001), P-tau (1·88, 1·79-1·97, p<0·0001), and Aβ42 (0·56, 0·55-0·58, p<0·0001). +1 more finding

  7. 2016-04-07
  8. 2016-04-06
  9. 2016-04-06

    There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS

    ✓ Peer-reviewed Clinical safety Brain research

    Key finding: Three major hypotheses have emerged and are still being hotly debated in the field. +4 more findings

  10. 2016-04-06

    The 2015 Dutch food-based dietary guidelines

    ✓ Peer-reviewed Risk factors European journal of clinical nutrition

    Key finding: A general guideline to eat a more plant food-based dietary pattern and limit consumption of animal-based food and 15 specific guidelines have been formulated. +4 more findings

  11. 2016-04-05

    Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer’s Disease: Phase 3 Study Design (S1.003)

    ✓ Peer-reviewed Treatments Neurology

    Key finding: ENGAGE and EMERGE are Phase 3 clinical trials designed to confirm the clinical efficacy and safety profile of aducanumab in individuals with Early AD.

  12. 2016-04-05

    PICALM rs3851179 Variant Confers Susceptibility to Alzheimer's Disease in Chinese Population

    ✓ Peer-reviewed Genetics Molecular neurobiology

    Key finding: However, these studies reported consistent and inconsistent results. +4 more findings

  13. 2016-04-05

    Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151)

    ✓ Peer-reviewed Genetics Molecular psychiatry

    Key finding: People's differences in cognitive functions are partly heritable and are associated with important life outcomes. +4 more findings

  14. 2016-04-05
  15. 2016-04-05

    TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus

    ✓ Peer-reviewed TREM2 and immune genetics Clinical epigenetics

    Key finding: Recent genome-wide association studies revealed TREM2 rs75932628-T variant to be associated with Alzheimer's disease (AD) and other neurodegenerative diseases. +3 more findings

  16. 2016-04-05

    Advanced brain aging: relationship with epidemiologic and genetic risk factors, and overlap with Alzheimer disease atrophy patterns

    ✓ Peer-reviewed Genetics Translational psychiatry

    Key finding: We systematically compared structural imaging patterns of advanced brain aging (ABA) in the general-population, herein defined as significant deviation from typical BA to those found in Alzheimer disease (AD). +4 more findings

  17. 2016-04-04

    Ensembles of Deep Learning Architectures for the Early Diagnosis of the Alzheimer's Disease

    ✓ Peer-reviewed Digital health tools International journal of neural systems

    Key finding: Two deep learning based structures and four different voting schemes are implemented and compared, giving as a result a potent classification architecture where discriminative features are computed in an unsupervised fashion. +1 more finding

  18. 2016-04-01

    Association Between Oral Health and Cognitive Status: A Systematic Review

    ✓ Peer-reviewed Digital health tools Journal of the American Geriatrics Society

    Key finding: It is unclear how or whether oral health and cognitive status are related. +1 more finding

  19. 2016-04-01

    The Effect of Decreased Audibility on MMSE Performance: A Measure Commonly Used for Diagnosing Dementia

    ✓ Peer-reviewed Risk factors Journal of the American Academy of Audiology

    Key finding: Apparent cognitive deficits based on MMSE scores obtained in test conditions in which audibility is reduced could result in incorrectly identified cognitive loss if clinicians are not alert to hearing loss when patients are evaluated. +1 more finding

  20. 2016-04-01

    Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides

    ✓ Peer-reviewed Drug development EMBO molecular medicine

    Key finding: These results reveal an association between ApoER2 isoform expression and AD, and provide preclinical evidence for the utility of ASOs as a therapeutic approach to mitigate Alzheimer's disease symptoms by improving ApoER2 exon 19 splicing.

  21. 2016-04-01

    Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia

    ✓ Peer-reviewed Brain scans and imaging Continuum (Minneapolis, Minn.)

    Key finding: This article provides an overview of the clinical features, neuropathologic findings, diagnostic criteria, and management of dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD), together known as the Lewy body dementias.

  22. 2016-04-01

    Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions

    ✓ Peer-reviewed Brain scans and imaging The Lancet. Neurology

    Key finding: Idiopathic rapid eye movement (REM) sleep behaviour disorder (IRBD) manifests as unpleasant dreams and vigorous behaviours during REM sleep that can result in injuries.

  23. 2016-04-01

    Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial

    ✓ Peer-reviewed Clinical safety JAMA

    Key finding: Among patients with agitated delirium receiving mechanical ventilation in the intensive care unit, the addition of dexmedetomidine to standard care compared with standard care alone (placebo) resulted in more ventilator-free hours at 7 days. +4 more findings

  24. 2016-04-01

    Adjuvant transcranial direct current stimulation for treating Alzheimer's disease: A case study

    ✓ Peer-reviewed Prevention trials Dementia & neuropsychologia

    Key finding: The data obtained revealed that the application of tDCS had a stabilizing effect on overall patient cognitive function and led to improved performance on all the secondary outcome tests. +1 more finding

  25. 2016-04-01

    Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Geriatrics Society

    Key finding: Of members initiated on an antimuscarinic OAB medication, 31.1% had a drug-drug or drug-disease or syndrome interaction. +4 more findings

Browse the library by subject, with the full score breakdown →